© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Lifecore Biomedical, Inc. (LFCR) stock remained unchanged at $4.09 a share on NASDAQ. The stock opened at $4.06, fluctuating between $4.04 to $4.27 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | 4.00 | 4.27 | 4.00 | 4.09 | 199.03K |
| Sep 09, 2026 | 4.29 | 4.31 | 4.03 | 4.09 | 264.78K |
| Sep 08, 2026 | 4.36 | 4.40 | 4.28 | 4.31 | 185.38K |
| Sep 04, 2026 | 4.35 | 4.60 | 4.29 | 4.40 | 277.09K |
| Sep 03, 2026 | 4.69 | 4.69 | 4.34 | 4.35 | 121.28K |
| Sep 02, 2026 | 4.42 | 4.80 | 4.42 | 4.74 | 235.9K |
| Sep 01, 2026 | 4.45 | 4.49 | 4.35 | 4.39 | 81.27K |
| Aug 31, 2026 | 4.50 | 4.61 | 4.45 | 4.46 | 88.01K |
| Aug 28, 2026 | 4.54 | 4.65 | 4.47 | 4.54 | 132.04K |
| Aug 27, 2026 | 4.64 | 4.70 | 4.53 | 4.54 | 122.34K |
| Aug 26, 2026 | 4.64 | 4.76 | 4.55 | 4.65 | 86.38K |
| Aug 25, 2026 | 4.55 | 4.83 | 4.55 | 4.64 | 113.41K |
| Aug 24, 2026 | 4.55 | 4.59 | 4.37 | 4.55 | 101.45K |
| Aug 21, 2026 | 4.58 | 4.70 | 4.50 | 4.54 | 90.55K |
| Aug 20, 2026 | 4.42 | 4.57 | 4.32 | 4.52 | 121.51K |
| Aug 19, 2026 | 4.43 | 4.73 | 4.40 | 4.46 | 111.98K |
| Aug 18, 2026 | 4.54 | 4.64 | 4.35 | 4.38 | 62.4K |
| Aug 17, 2026 | 4.65 | 4.65 | 4.45 | 4.54 | 134.28K |
| Aug 14, 2026 | 4.67 | 4.75 | 4.47 | 4.72 | 142.18K |
| Aug 13, 2026 | 4.78 | 4.85 | 4.69 | 4.73 | 93.49K |
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
| Employees | 382 |
| Beta | 1.09 |
| Sales or Revenue | $129.46M |
| 5Y Sales Change% | 0.13% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |